Targeting TKI-Activated NFKB2-MIF/CXCLs-CXCR2 Signaling Pathways in FLT3 Mutated Acute Myeloid Leukemia Reduced Blast Viability.
Cao H, Tadros V, Hiramoto B, Leeper K, Hino C, Xiao J, Pham B, Kim DH, Reeves ME, Chen CS, Zhong JF, Zhang KK, Xie L, Wasnik S, Baylink DJ, Xu Y.
Cao H, et al. Among authors: hiramoto b.
Biomedicines. 2022 Apr 30;10(5):1038. doi: 10.3390/biomedicines10051038.
Biomedicines. 2022.
PMID: 35625776
Free PMC article.